Loading…
Loading…
EQUITY / NASDAQ · XNCM
Creative Medical Technology Holdings, Inc.
01 / RESEARCH
8 financial reports are available for research.
Start research ↗0.93 USD · -0.4922%
Observed: Oct 1, 2026, 8:55 AM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
09/30/2026 · 0.9346 USD · Volume 97,471
251 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | Prior year | Change |
|---|---|---|---|
| Gross profit | 0 USD | — | — |
| Net income | -1,511,976 USD | — | — |
| Operating profit | -1,562,163 USD | — | — |
| Revenue | 0 USD | — | — |
| Total assets | 9,377,653 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 1ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Gross profitIncome statement | 0 USD | 0 USD | — | 0 USD | — | 3,806 USD | 0 USD | 1,800 USD |
| Net incomeIncome statement | -1,511,976 USD | -2,917,053 USD | — | -1,405,077 USD | — | -5,995,008 USD | -1,235,934 USD | -4,107,334 USD |
| Operating profitIncome statement | -1,562,163 USD | -3,021,316 USD | — | -1,459,153 USD | — | -6,142,814 USD | -1,273,034 USD | -4,197,032 USD |
| RevenueIncome statement | 0 USD | 0 USD | — | 0 USD | — | 6,000 USD | 0 USD | 3,000 USD |
| Total assetsBalance sheet | 9,377,653 USD | — | — | 6,440,577 USD | 7,809,525 USD | 7,809,525 USD | 5,853,003 USD | — |
| Total equityBalance sheet | 8,654,972 USD | — | 6,132,928 USD | 6,109,568 USD | 7,514,645 USD | 7,514,645 USD | 5,591,650 USD | — |
| Total liabilitiesBalance sheet | 698,595 USD | — | — | 307,649 USD | 284,880 USD | 284,880 USD | 261,353 USD | — |
| Financing cash flowCash flow statement | — | 4,476,544 USD | — | 13,360 USD | — | 7,174,669 USD | — | 3,354,000 USD |
| Investing cash flowCash flow statement | — | -175,000 USD | — | -175,000 USD | — | -50,500 USD | — | 0 USD |
| Operating cash flowCash flow statement | — | -2,795,555 USD | — | -1,323,310 USD | — | -5,856,445 USD | — | -3,918,891 USD |
| Report source | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 05/08/2026 | Open report ↗ Published: 08/07/2026 | Open report ↗ Published: 03/20/2026 | Open report ↗ Published: 11/07/2025 | Open report ↗ Published: 11/07/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.